230 related articles for article (PubMed ID: 12268337)
1. On 7/7/7 preferred for new patients by 47% of respondents.
Contracept Technol Update; 1986 Sep; 7(9):101-4. PubMed ID: 12268337
[TBL] [Abstract][Full Text] [Related]
2. Three triphasic oral contraceptives now available in U.S.
Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
[TBL] [Abstract][Full Text] [Related]
3. ON 7/7/7 is first choice for 60% of CTU survey respondents.
Contracept Technol Update; 1987 Sep; 8(9):109-12. PubMed ID: 12268910
[TBL] [Abstract][Full Text] [Related]
4. Experts debate pill switching to combat noncompliance. Special report: annual pill survey.
Contracept Technol Update; 1992 Oct; 13(10):149-53. PubMed ID: 12344722
[TBL] [Abstract][Full Text] [Related]
5. Might generic OCs create contraceptive price war?
Contracept Technol Update; 1987 Feb; 8(2):13-7. PubMed ID: 12314977
[TBL] [Abstract][Full Text] [Related]
6. The triphasics: insights for effective clinical use.
Youngkin EQ; Miller LG
Nurse Pract; 1987 Feb; 12(2):17-8, 23, 26-8. PubMed ID: 3822267
[TBL] [Abstract][Full Text] [Related]
7. Young teens are safe on pills but need counseling, follow-up.
Contracept Technol Update; 1987 Sep; 8(9):120-2. PubMed ID: 12268914
[TBL] [Abstract][Full Text] [Related]
8. Designating types of OCs in family planning agency can save money.
Contracept Technol Update; 1985 Jan; 6(1):6-7. PubMed ID: 12279917
[TBL] [Abstract][Full Text] [Related]
9. [Oral contraception: evolution of concepts over the last thirty years].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408
[TBL] [Abstract][Full Text] [Related]
10. Approaches vary in managing the over-40 pill patient.
Contracept Technol Update; 1988 Sep; 9(9):105-7. PubMed ID: 12342192
[TBL] [Abstract][Full Text] [Related]
11. Pill won't budge from no. 1 spot: half of women leave exams with OCs.
Contracept Technol Update; 2000 Sep; 21(9):101-4. PubMed ID: 12296239
[TBL] [Abstract][Full Text] [Related]
12. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
[TBL] [Abstract][Full Text] [Related]
13. Pill power: oral contraceptives hold top spot in family planning arsenal.
Contracept Technol Update; 1998 Oct; 19(10):125-7. PubMed ID: 12321842
[TBL] [Abstract][Full Text] [Related]
14. OCs are currently the second most popular birth control method in U.S.
Contracept Technol Update; 1985 Jan; 6(1):3. PubMed ID: 12279916
[TBL] [Abstract][Full Text] [Related]
15. An update on the pill.
Initiatives Popul; 1983; 7(3):2-15. PubMed ID: 12339841
[TBL] [Abstract][Full Text] [Related]
16. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
17. [Oral contraception: failures and risks].
Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
[TBL] [Abstract][Full Text] [Related]
18. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
American Health Consultants
Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives hold top position as leading choice for women.
Contracept Technol Update; 1997 Nov; 18(11):133-6. PubMed ID: 12292767
[TBL] [Abstract][Full Text] [Related]
20. Clinicians choose distinctive approaches to OC management.
Contracept Technol Update; 1987 Sep; 8(9):118-20. PubMed ID: 12268913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
